Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00720694 · ClinicalTrials.gov registry record · Phase 3
Study of Effectiveness and Safety of Extracorporeal Shock Wave Therapy (ESWT) for Treatment of Painful Heel Syndrome
A Phase 3 study of Plantar Fasciitis, sponsored by Storz Medical.
- Completed
- Registry status
- Phase 3
- Development phase
- 250
- Enrollment target
- 6
- Study locations
NCT00720694 is a Phase 3 study of Plantar Fasciitis that has completed, run by Storz Medical. The registered enrollment target is 250 participants, above the 67-participant average among 6 other Plantar Fasciitis trials with a reported enrollment target (273% higher). The trial reports 6 study locations across 5 states.
The verdict
NCT00720694, a Phase 3 study of Plantar Fasciitis, has completed, sponsored by Storz Medical.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 250 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to determine if the Storz Duolith SD1 is more effective than placebo for treatment of heel pain syndrome for patients who have failed conservative treatment with other therapies.
Conditions Studied
Interventions
- DEVICE Duolith SD1
- DEVICE Sham Duolith SD1
Study Locations (6)
Connecticut
- Connecticut Orthopedics Specialists - Hamden
- Advanced Footcare Specialists of Connecticut, LLC - Newtown
California
- Palo Alto Medical Fondation - Palo Alto
New York
- Galli Podiatric Foot and Ankle Associates - New York
Ohio
- Ankle and Foot Care Centers - Boardman
Washington
- The Sports Medicine Clinic - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2006-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00720694
The ClinicalTrials.gov registry entry for NCT00720694 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 67-participant average among 6 other Plantar Fasciitis trials with a reported enrollment target (273% higher). The listed sponsor is Storz Medical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Plantar Fasciitis appearing as the primary indexed condition, and to 2 interventions - of which Duolith SD1 is the first listed.
NCT00720694 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Connecticut, California, New York.
Frequently Asked Questions
What is clinical trial NCT00720694 about?
NCT00720694 is a clinical study titled "Study of Effectiveness and Safety of Extracorporeal Shock Wave Therapy (ESWT) for Treatment of Painful Heel Syndrome". The purpose of this study is to determine if the Storz Duolith SD1 is more effective than placebo for treatment of heel pain syndrome for patients who have failed conservative treatment with other therapies.
What is the current status of trial NCT00720694?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 250 participants. The study started on 2006-06.
What conditions does trial NCT00720694 study?
This clinical trial studies the following conditions: Plantar Fasciitis.
What interventions are being tested in trial NCT00720694?
The interventions under investigation include: Duolith SD1 (DEVICE), Sham Duolith SD1 (DEVICE).
Who is sponsoring clinical trial NCT00720694?
This trial is sponsored by Storz Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00720694 being conducted?
This trial has 6 study locations across California, Connecticut, New York, Ohio, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Plantar Fasciitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lateral Plantar Artery Embolization For Plantar Fasciitis
RECRUITING · Phase 1
-
The Effects of Terrain Variation on Intrinsic Foot Musculature in Healthy Individuals and Individuals With Plantar Fasciitis
RECRUITING · NA
-
Phase 2 DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis
COMPLETED · Phase 2
-
Treatment of Plantar Fasciitis With Dorsiflexion Night Splints and Medial Arch Supports
COMPLETED · Phase 4
-
DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis
COMPLETED · Phase 2
-
Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar Fasciitis
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.